23,800 Ally (ALLY) shares bought by trust tied to CEO Rhodes

Rhea-AI Filing Summary

Ally Financial Inc. reported an insider share purchase involving its Chief Executive Officer, Michael George Rhodes. On January 23, 2026, a trust of which he is the sole beneficiary bought 23,800 shares of Ally common stock in open-market transactions at a weighted average price of $41.6751 per share, with individual trade prices ranging from $41.34 to $41.88. Following this purchase, the trust holds 49,434 shares indirectly attributed to Rhodes, while he also holds 290,947 shares directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RHODES MICHAEL GEORGE

(Last) (First) (Middle)

500 WOODWARD AVENUE

(Street)

DETROIT MI 48226

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ally Financial Inc. [ ALLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/23/2026		P		23,800	A	$41.6751(1)	49,434	I	See Footnote(2)
Common Stock								290,947	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.34 to $41.88, inclusive. The reporting person undertakes to provide to Ally Financial Inc., any security holder of Ally Financial Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. Represents shares held by a trust of which the reporting person is the sole beneficiary.

Remarks:

	/s/ Joyce M. Daniels, attorney-in-fact for Michael G. Rhodes	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ALLY report for Michael George Rhodes?

Ally Financial Inc. reported that a trust associated with Chief Executive Officer Michael George Rhodes purchased 23,800 shares of Ally common stock on January 23, 2026.

At what price did the CEO-linked trust buy Ally (ALLY) shares?

The trust bought the shares at a weighted average price of $41.6751 per share, with individual trades executed between $41.34 and $41.88 per share.

How many Ally (ALLY) shares does the CEO now hold indirectly through the trust?

After the reported transaction, the trust of which Michael George Rhodes is the sole beneficiary holds 49,434 Ally common shares attributed to him as indirect ownership.

How many Ally (ALLY) shares does the CEO hold directly?

In addition to the trust holdings, Michael George Rhodes is shown as directly holding 290,947 shares of Ally common stock following the reported transaction.

Was the Ally (ALLY) CEO transaction a purchase or a sale?

The Form 4 shows a transaction code P, indicating that the CEO-linked trust purchased 23,800 Ally common shares in the open market.

Who executed the Ally (ALLY) Form 4 for this transaction?

The Form 4 was signed by Joyce M. Daniels as attorney-in-fact for Michael G. Rhodes on January 23, 2026.